233 related articles for article (PubMed ID: 24152582)
1. Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion.
Fischer G; Pan B; Vilceanu D; Hogan QH; Yu H
Gene Ther; 2014 Jan; 21(1):44-51. PubMed ID: 24152582
[TBL] [Abstract][Full Text] [Related]
2. AAV-encoded Ca
Yu H; Shin SM; Xiang H; Chao D; Cai Y; Xu H; Khanna R; Pan B; Hogan QH
Gene Ther; 2019 Aug; 26(7-8):308-323. PubMed ID: 31118475
[TBL] [Abstract][Full Text] [Related]
3. Primary sensory neuron-specific interference of TRPV1 signaling by AAV-encoded TRPV1 peptide aptamer attenuates neuropathic pain.
Xiang H; Liu Z; Wang F; Xu H; Roberts C; Fischer G; Stucky C; Caron D; Pan B; Hogan Q; Yu H
Mol Pain; 2017; 13():1744806917717040. PubMed ID: 28604222
[TBL] [Abstract][Full Text] [Related]
4. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
[TBL] [Abstract][Full Text] [Related]
5. CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.
Piekarz AD; Due MR; Khanna M; Wang B; Ripsch MS; Wang R; Meroueh SO; Vasko MR; White FA; Khanna R
Mol Pain; 2012 Jul; 8():54. PubMed ID: 22828369
[TBL] [Abstract][Full Text] [Related]
6. Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.
Xie JY; Chew LA; Yang X; Wang Y; Qu C; Wang Y; Federici LM; Fitz SD; Ripsch MS; Due MR; Moutal A; Khanna M; White FA; Vanderah TW; Johnson PL; Porreca F; Khanna R
Pain; 2016 Sep; 157(9):2124-2140. PubMed ID: 27537210
[TBL] [Abstract][Full Text] [Related]
7. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.
Moutal A; Li W; Wang Y; Ju W; Luo S; Cai S; François-Moutal L; Perez-Miller S; Hu J; Dustrude ET; Vanderah TW; Gokhale V; Khanna M; Khanna R
Br J Pharmacol; 2018 Jun; 175(12):2244-2260. PubMed ID: 28161890
[TBL] [Abstract][Full Text] [Related]
8. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.
Brittain JM; Duarte DB; Wilson SM; Zhu W; Ballard C; Johnson PL; Liu N; Xiong W; Ripsch MS; Wang Y; Fehrenbacher JC; Fitz SD; Khanna M; Park CK; Schmutzler BS; Cheon BM; Due MR; Brustovetsky T; Ashpole NM; Hudmon A; Meroueh SO; Hingtgen CM; Brustovetsky N; Ji RR; Hurley JH; Jin X; Shekhar A; Xu XM; Oxford GS; Vasko MR; White FA; Khanna R
Nat Med; 2011 Jun; 17(7):822-9. PubMed ID: 21642979
[TBL] [Abstract][Full Text] [Related]
9. Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.
Chi XX; Schmutzler BS; Brittain JM; Wang Y; Hingtgen CM; Nicol GD; Khanna R
J Cell Sci; 2009 Dec; 122(Pt 23):4351-62. PubMed ID: 19903690
[TBL] [Abstract][Full Text] [Related]
10. Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.
Wilson SM; Brittain JM; Piekarz AD; Ballard CJ; Ripsch MS; Cummins TR; Hurley JH; Khanna M; Hammes NM; Samuels BC; White FA; Khanna R
Channels (Austin); 2011; 5(5):449-56. PubMed ID: 21829088
[TBL] [Abstract][Full Text] [Related]
11. Targeting intrinsically disordered regions facilitates discovery of calcium channels 3.2 inhibitory peptides for adeno-associated virus-mediated peripheral analgesia.
Shin SM; Lauzadis J; Itson-Zoske B; Cai Y; Fan F; Natarajan GK; Kwok WM; Puopolo M; Hogan QH; Yu H
Pain; 2022 Dec; 163(12):2466-2484. PubMed ID: 35420557
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of N-type calcium channels in the soma of uninjured dorsal root ganglion neurons contributes to neuropathic pain by increasing neuronal excitability following peripheral nerve injury.
Yang J; Xie MX; Hu L; Wang XF; Mai JZ; Li YY; Wu N; Zhang C; Li J; Pang RP; Liu XG
Brain Behav Immun; 2018 Jul; 71():52-65. PubMed ID: 29709527
[TBL] [Abstract][Full Text] [Related]
13. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
Feldman P; Khanna R
Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
[TBL] [Abstract][Full Text] [Related]
14. Selective block of sensory neuronal T-type/Cav3.2 activity mitigates neuropathic pain behavior in a rat model of osteoarthritis pain.
Itson-Zoske B; Shin SM; Xu H; Qiu C; Fan F; Hogan QH; Yu H
Arthritis Res Ther; 2022 Jul; 24(1):168. PubMed ID: 35842727
[TBL] [Abstract][Full Text] [Related]
15. Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons.
Pleticha J; Jeng-Singh C; Rezek R; Zaibak M; Beutler AS
Mol Cell Neurosci; 2014 May; 60():72-80. PubMed ID: 24769104
[TBL] [Abstract][Full Text] [Related]
16. A peptidomimetic modulator of the Ca
Gomez K; Santiago U; Nelson TS; Allen HN; Calderon-Rivera A; Hestehave S; Rodríguez Palma EJ; Zhou Y; Duran P; Loya-Lopez S; Zhu E; Kumar U; Shields R; Koseli E; McKiver B; Giuvelis D; Zuo W; Inyang KE; Dorame A; Chefdeville A; Ran D; Perez-Miller S; Lu Y; Liu X; Handoko ; Arora PS; Patek M; Moutal A; Khanna M; Hu H; Laumet G; King T; Wang J; Damaj MI; Korczeniewska OA; Camacho CJ; Khanna R
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2305215120. PubMed ID: 37972067
[TBL] [Abstract][Full Text] [Related]
17. Virus-mediated shRNA knockdown of Na(v)1.3 in rat dorsal root ganglion attenuates nerve injury-induced neuropathic pain.
Samad OA; Tan AM; Cheng X; Foster E; Dib-Hajj SD; Waxman SG
Mol Ther; 2013 Jan; 21(1):49-56. PubMed ID: 22910296
[TBL] [Abstract][Full Text] [Related]
18. Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.
Brittain JM; Pan R; You H; Brustovetsky T; Brustovetsky N; Zamponi GW; Lee WH; Khanna R
Channels (Austin); 2012; 6(1):52-9. PubMed ID: 22373559
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Ca
Liu QY; Chen W; Cui S; Liao FF; Yi M; Liu FY; Wan Y
Neurosci Res; 2019 May; 142():30-37. PubMed ID: 29684385
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons.
Leo M; Schmitt LI; Erkel M; Melnikova M; Thomale J; Hagenacker T
Exp Neurol; 2017 Feb; 288():62-74. PubMed ID: 27823926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
